SGHT
HEALTHCARESight Sciences Inc
What's Moving SGHT Today?
No stock-specific AI insight has been generated for SGHT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.41
Fundamentals
Trading
SGHT News
21 articles- Discover 3 Promising Penny Stocks With Market Caps Over $20MYahoo Finance·Jun 9, 2026
- Sight Sciences Financial Results for Q1 2026 Show GrowthVisionMonday.com·May 8, 2026
- Sight Sciences Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Sight Sciences, Inc. Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesYahoo Finance·May 6, 2026
- Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- Sight Sciences (SGHT) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue GuidanceYahoo Finance·May 6, 2026
- Sight Sciences to Present at Two Upcoming Investor ConferencesYahoo Finance·Apr 29, 2026
- Fuel Tech Leads The Pack Of 3 Noteworthy Penny StocksYahoo Finance·Apr 29, 2026
- Sight Sciences Announces the Release of its Sustainability ReportYahoo Finance·Apr 22, 2026
- Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026Yahoo Finance·Apr 21, 2026
- Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingYahoo Finance·Apr 1, 2026
- Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13thYahoo Finance·Mar 30, 2026
- Arq And 2 Other Promising Penny StocksYahoo Finance·Mar 30, 2026
- Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® MicrostentYahoo Finance·Mar 30, 2026
- Sight Sciences, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 5, 2026
- Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...Yahoo Finance·Mar 5, 2026
- Sight Sciences Q4 Earnings Call HighlightsMarketbeat·Mar 5, 2026
- Sight Sciences (SGHT) Q4 2025 Earnings TranscriptMotley Fool·Mar 4, 2026
- Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to SayYahoo Finance·Mar 4, 2026
All 21 articles loaded
Price Data
52-Week Range
$5.41
Fundamentals
Trading
About Sight Sciences Inc
Sight Sciences Inc. (SGHT) is a leading medical technology company dedicated to innovating the treatment of ocular diseases, particularly through advanced solutions for glaucoma management. With a strong focus on both surgical and non-surgical methods, the company boasts a diverse product portfolio complemented by a comprehensive intellectual property strategy. As the demand for minimally invasive ophthalmic therapies continues to grow, Sight Sciences is strategically positioned to capture market share and enhance patient outcomes. Its commitment to advancing eye care technology and optimizing its distribution network presents a valuable investment opportunity within the rapidly evolving healthcare landscape.